Cargando…
Telmisartan versus EnalapRil In heart failure with redUced ejection fraction patients with Moderately impaired kidney Functions; randomized controlled trial: “TRIUMF trial”
BACKGROUND: When heart failure with reduced ejection fraction (HFrEF) and chronic kidney disease (CKD) co-exist, Renin angiotensin-aldosterone system inhibitors (RAASi) are often underutilized for the fear of worsening renal function (WRF). Telmisartan is a RAASi characteristic for a favorable renal...
Autores principales: | Samir, Ahmad, Aboel-Naga, Salma, Shehata, Ahmed, Abdelhamid, Magdy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409965/ https://www.ncbi.nlm.nih.gov/pubmed/37552407 http://dx.doi.org/10.1186/s43044-023-00398-7 |
Ejemplares similares
-
Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Saha, Lekha
Publicado: (2011) -
Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Akat, Pramod B., et al.
Publicado: (2010) -
Effect of telmisartan and enalapril on ventricular remodeling and kidney prognosis of patients with coronary artery disease complicated with diabetic nephropathy
por: Hou, Yuyan, et al.
Publicado: (2017) -
TRIUMF: Secrets of the red giant
Publicado: (1993) -
Ultraconserved elements (UCEs) resolve the phylogeny of Australasian smurf-weevils
por: Van Dam, Matthew H., et al.
Publicado: (2017)